In First For US OTC Market, Advil Line Extension Combines Ibuprofen And Acetaminophen

CDER approval of Pfizer's NDA introduces a new formulation to the US OTC market. Labeling for was approved with the requirement of adding bullet points for an “Acetaminophen liver damage warning” and an “NSAID stomach bleeding warning” on all immediate containers.

GSK adn pfizer building signage

The first OTC drug containing ibuprofen and acetaminophen will be available in the US from GlaxoSmithKline PLC following regulatory approval of a formulation that will be marketed as an Advil line extension.

The Food and Drug Administration’s 28 February approval of a new drug application for 125-mg ibuprofen and 250-mg acetaminophen tablet...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health